Brazil develops own H1N1 diagnostic, rewrites tech-dependency rules
This article was originally published in Clinica
Brazil no longer needs to import tests for H1N1 flu, after developing a kit that is "cheaper, faster and more reliable" than others on the market, the government has announced.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.